MedPath
HSA Approval

ZAFIBRAL TABLET 200 mg

SIN10217P

ZAFIBRAL TABLET 200 mg

ZAFIBRAL TABLET 200 mg

October 8, 1998

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDOCHEMIE SINGAPORE PTE. LTD.
Licence HolderMEDOCHEMIE SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C10AB02

bezafibrate

Manufacturer Information

MEDOCHEMIE SINGAPORE PTE. LTD.

MEDOCHEMIE LTD (CENTRAL FACTORY)

Active Ingredients

BEZAFIBRATE

200 mg

Bezafibrate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.